Page last updated: 2024-12-07

3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid: structure given in first source; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91658
CHEBI ID39308
SCHEMBL ID192771
MeSH IDM0189929

Synonyms (53)

Synonym
BB 0261358
1r-cis-permethrinic acid
3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid
CHEBI:39308 ,
3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid
55701-05-8
3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid
einecs 259-768-2
cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-
STK809740
AKOS000267381
3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylic acid
permethric acid
A830761
3-[2,2-bis(chloranyl)ethenyl]-2,2-dimethyl-cyclopropane-1-carboxylic acid
3-(2,2-dichloroethenyl)-2,2-dimethyl-1-cyclopropanecarboxylic acid
FT-0640331
AKOS016039119
SCHEMBL192771
2,2-dimethyl-3-(2',2'-dichlorovinyl)-cyclopropanecarboxylic acid
2,2-dimethyl-3-(2,2-dichlorovinyl)cyclopropane-1-carboxylic acid
2,2-dimethyl-3-(2,2-dichlorovinyl)cyclopropanecarboxylic acid
3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylic acid
2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane-carboxylic acid
3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid
2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropanecarboxylic acid
3-(2,2-dichloro-vinyl)-2,2-dimethylcyclopropane-1-carboxylic acid
2,2-dimethyl-3-(2',2'-dichlorovinyl)-cyclopropane-carboxylic acid
3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid
2-(2',2'-dichlorovinyl)-3,3-dimethylcyclopropane-1-carboxylic acid
2,2-dimethyl-3-(2,2-dichlorovinyl) cyclopropane carboxylic acid
LLMLSUSAKZVFOA-UHFFFAOYSA-N
2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylic acid
2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane-1-carboxylic acid
2,2-dimethyl-3-(2',2'-dichlorovinyl) cyclopropanecarboxylic acid
2,2-dimethyl-3-(2,2-dichlorovinyl)cyclopropane carboxylic acid
3-(2,2-dichlorovinyl)-2,2-dimethyl-1-cyclopropanecarboxylic acid
DTXSID5028039
cis-dl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid
mfcd00137937
permethrinic acid 10 microg/ml in methanol
beta-cyfluthrin tp2
FT-0700671
3-(2,2-dichlorovinyl)-2,2-dimethyl-(1-cyclopropane)carboxylicacid
CS-0206089
3-(2,2-dichloroethyenyl)-2,2-dimethylcyclopropanecarboxylic acid
Q27119806
3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylicacid
FT-0701335
trans-permethrinic acid 100 microg/ml in acetonitrile
SB47946
permethrinic acid 100 microg/ml in acetonitrile
LS-03917

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Following oral dosing approx."( The metabolism of cypermethrin in man: differences in urinary metabolite profiles following oral and dermal administration.
Laird, WJ; Lesser, JE; Marsh, JR; Woollen, BH, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's5 (31.25)29.6817
2010's8 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.80 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.88%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]